-
Impact of Interventions on Medication Adherence and Blood Pressure Control in Patients with Essential Hypertension: A Systematic Review by the ISPOR Medication Adherence and Persistence Special Interest Group
-
A Systematic Literature Review of Gaps and Challenges in Value Assessment of Biosimilars
-
Performance-Based Risk-Sharing Arrangements - Good Practices for Design, Implementation and Evaluation
-
Pediatric Patient-Reported Outcome Instruments for Research to Support Medical Product Labeling
-
Validation of Electronic Systems to Collect Patient-Reported Outcome (PRO) Data - Recommendations for Clinical Trial Teams
-
Checklist for Ascertaining Study Cohorts in Oncology Health Services Research Using Secondary Data
-
Constructing Experimental Designs for Discrete-Choice Experiments
-
Prospective Observational Studies to Assess Comparative Effectiveness
-
Modeling Good Research Practices - Overview: Report 1
-
Challenges in the Development and Reimbursement of Personalized Medicine—Payer and Manufacturer Perspectives and Implications for Health Economics and Outcomes Research
-
Conceptualizing a Model: Report 2
-
State-Transition Modeling: Report 3
-
Modeling Using Discrete Event Simulation: Report 4
-
Dynamic Transmission Modeling: Report 5
-
Model Parameter Estimation and Uncertainty Analysis: Report 6
-
Model Transparency and Validation: Report 7
-
Content Validity - Establishing and Reporting the Evidence in Newly Developed Patient-Reported Outcomes (PRO) Instruments for Medical Product Evaluation Part 1
-
Content Validity – Establishing and Reporting the Evidence in Newly Developed Patient-Reported Outcomes (PRO) Instruments for Medical Product Evaluation Part 2
-
Interpreting Indirect Treatment Comparisons and Network Meta-Analysis for Health-Care Decision Making Report 1
-
Conducting Indirect Treatment Comparison and Network Meta-Analysis Studies Report 2
Questions?
For any questions about this report please contact us.